It what may be a first since the early days of the war between the U.S. and Iran, a Wall Street firm is lowering rather than raising its S&P 500 year-end target.
Əlaqəli xəbərlər
How CRE Leasing Pros Can Take AI to the Next Level
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Ballooning US debt is a ticking time bomb, billionaire investor David Rubenstein says
India’s Allied Blenders readies move into single-malt whisky
Tabby secures $233m in equity round, valuation climbs to $6.5bn
Advance Auto Parts vs. Rocket Lab: Which Consumer Stock Is a Better Buy in 2026?